Latest Breaking News On - Attralus inc - Page 1 : comparemela.com

Novel Radiotracer Produces High Quality Images of Alzheimer s Disease of the Heart

Novel Radiotracer Produces High Quality Images of Alzheimer s Disease of the Heart
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of tennesseeDrug administrationUniversity of tennessee graduate school medicineSociety of nuclear medicineAttralus incNuclear medicineMolecular imaging annualJonathan wallTennessee graduate school

New Arrows Aimed at Tau: Single-Domain Antibody, Peptibody, Vaccine

New Arrows Aimed at Tau: Single-Domain Antibody, Peptibody, Vaccine
alzforum.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzforum.org Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSan franciscoVastra gotalands lanMerritt islandUniversity of texasSouth koreaEinar sigurdssonSuganya selvarajahMadolyn bowman rogersWilliam mcewanJustin boydSouthwestern medical centerYork university school of medicineAttralus incInternational conference on alzheimer

Attralus Receives FDA and EMA Orphan Designation for AT-01

SAN FRANCISCO, Dec. 19, 2022 (GLOBE NEWSWIRE) Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to.

United statesSan franciscoGregory bellIsabelle lousadaKrishna gortiUniversity of tennessee medical centerEuropean commissionDrug administrationAttralus incUniversity of tennessee research foundationAttralus communicationsCommittee for orphan medicinal productsEuropean medicines agencyAmyloidosis research consortiumOrphan medicinal productsChief medical officer

Attralus Announces New Clinical Data in ATTR CM and AL With AT-01 (Iodine (I-124) Evuzamitide), a Novel Amyloid-Specific Imaging Agent

AT-01 shows increased LV uptake and LV amyloid activity in all cardiac ATTR and AL subjects, but in none of the controls (100% accuracy) AT-01 demonstrates

United statesBaden wübergSan franciscoOlivier clercLuke heagleSharmila dorbalaGregory bellInternational symposium on amyloidosisResearch fellow amyloidosis programOutcomes research poster abstractsNuclear cardiologyAttralus incHealthcare pharmaceuticals industryUniversity of tennessee research foundationAmerican society of nuclear cardiologyInternational symposium

Attralus Announces New Clinical Data in ATTR CM and AL With

AT-01 shows increased LV uptake and LV amyloid activity in all cardiac ATTR and AL subjects, but in none of the controls (100% accuracy)AT-01 demonstrates.

United statesBaden wübergSan franciscoOlivier clercLuke heagleSharmila dorbalaGregory bellInternational symposium on amyloidosisAttralus incResearch fellow amyloidosis programUniversity of tennessee research foundationOutcomes research poster abstractsNuclear cardiologyAmerican society of nuclear cardiologyInternational symposiumAmerican society